BSECompany UpdateMgmt Change1d ago
LINCOLN PHARMACEUTICALS LIMITED
LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Lincoln Pharmaceuticals Limited has informed BSE about the appointment of a Sr. General Manager - XBRL.
BSECompany UpdateMgmt Change1d ago
Lincoln Pharmaceuticals Ltd
We wish to informed you that Mr. Pradeep Kumar Yadav has been appointed as " Senior General Manager- Quality Assurance (Senior Management Personnel) of the Company w.e.f 24-09-2026.
Lincoln Pharmaceuticals Ltd has appointed Mr. Pradeep Kumar Yadav as Senior General Manager- Quality Assurance, effective September 24, 2026.
BSECompany UpdateMgmt Change1d ago
Lincoln Pharmaceuticals Ltd
Change in Senior Management.
Lincoln Pharmaceuticals Ltd has announced the resignation of Mr. Manoj Rai, Sr. General Manager- QA (Head QA), due to personal reasons, effective September 24, 2026.
BSEInsider Trading / SASTResults2d ago
Lincoln Pharmaceuticals Ltd
Intimation of Closure of Trading Window.
Lincoln Pharmaceuticals Ltd has announced the closure of its trading window from October 1, 2026, till 48 hours after the declaration of its financial results for the quarter ended September 30, 2026. The company has informed its directors, senior management personnel, promoters, and connected persons not to trade in its securities during this period.
BSECorp. ActionDividend29 Aug 2026
Lincoln Pharmaceuticals Ltd
The intimation of Book Closure and Record date is as enclosed.
Lincoln Pharmaceuticals Ltd has announced the book closure and record date for its 32nd Annual General Meeting and final dividend for the financial year 2025-26. The final dividend is ₹ 1.80 per equity share, and the meeting is scheduled for September 30, 2026.
BSECorp. ActionDividend29 Aug 2026
Lincoln Pharmaceuticals Ltd
Pursuant to Regulation 42 of SEBI (LODR) Regulations, 2015, we would like to inform you that the 32nd Annual General Meeting of the Company is scheduled to be held on Wednesday, September ....
Lincoln Pharmaceuticals Ltd has announced the 32nd Annual General Meeting (AGM) scheduled for September 30, 2026, to determine the entitlement of members for payment of a final dividend of ₹ 1.80 per equity share, if approved.
BSECompany Update26 Aug 2026
Lincoln Pharmaceuticals Ltd
Newspaper Advertisement regarding the 32nd Annual General Meeting of the Company to be held on Wednesday, September 30, 2026.
Lincoln Pharmaceuticals Ltd has published a newspaper advertisement regarding its 32nd Annual General Meeting (AGM) to be held on September 30, 2026, through video conferencing.
BSECompany UpdateResults14 Aug 2026
Lincoln Pharmaceuticals Ltd
We enclosed herewith the copies of newspaper intimation with respect to the unaudited (standalone & Consolidated) Financial Results of the Company for the Quarter Ended 30 June, 2026.
Lincoln Pharmaceuticals Ltd has announced the unaudited financial results for the quarter ended June 30, 2026, as per Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has published the results in the Financial Express newspaper in English and Gujarati.
BSEResultResults13 Aug 2026
Lincoln Pharmaceuticals Ltd
Un-Audited Financial Results For Quarter Ended on 30 June, 2026.
Lincoln Pharmaceuticals Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with a net profit of ₹3,623.45 lakhs and earnings per share of ₹18.09.
BSEBoard MeetingResults13 Aug 2026
Lincoln Pharmaceuticals Ltd
Un-Audited Financial Results of the Company For the Quarter Ended June 30, 2026.
Lincoln Pharmaceuticals Ltd has announced its un-audited financial results for the quarter ended June 30, 2026, with a net profit of ₹3,623.45 lakhs and earnings per share of ₹18.09.
BSEBoard MeetingResults6 Aug 2026
Lincoln Pharmaceuticals Ltd
Lincoln Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Lincoln Pharmaceuticals ....
Lincoln Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 13/08/2026 to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.